Showing results (111-120 of 150) with videos related to

Sort By:
Pageof 15
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|May 22, 2001
The hippurate ratio as an indicator of functional hepatic reserve for resection of hepatocellular carcinoma in cirrhotic patientsA W Hemming, S Gallinger, P D Greig, et al.
Human Molecular Genetics|April 10, 1999
Mismatch repair gene defects contribute to the genetic basis of double primary cancers of the colorectum and endometriumA L Millar, T Pal, L Madlensky, et al.
Cancer Research|January 15, 1993
Comparative dual label study of first and second generation antitumor-associated glycoprotein-72 monoclonal antibodies in colorectal cancer patientsS Gallinger, R M Reilly, J C Kirsh, et al.
Clinical Genetics|September 3, 2011
Development and validation of an instrument to measure the impact of genetic testing on self-concept in Lynch syndromeM J Esplen, N Stuckless, S Gallinger, et al.
The British Journal of Surgery|September 17, 2013
Outcomes after hepatic resection and subsequent multimodal treatment of recurrence for multifocal hepatocellular carcinomaP T W Kim, J-H Jang, E G Atenafu, et al.
Cancer Research|July 1, 1996
MSH2 deficiency contributes to accelerated APC-mediated intestinal tumorigenesisA H Reitmair, J C Cai, M Bjerknes, et al.
Oncogene|April 12, 2011
Type IV collagen-initiated signals provide survival and growth cues required for liver metastasisJ V Burnier, N Wang, R P Michel, et al.
The British Journal of Surgery|August 14, 2013
Planned versus unplanned portal vein resections during pancreaticoduodenectomy for adenocarcinomaP T W Kim, A C Wei, E G Atenafu, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 28, 2014
Induction gemcitabine plus concurrent gemcitabine and radiotherapy for locally advanced unresectable or resected pancreatic cancerM Youl, S Hashem, A Brade, et al.
Breast Cancer Research and Treatment|August 1, 1997
Pre-operative assessment of axillary lymph node status in patients with breast adenocarcinoma using intravenous 99mtechnetium mAb-170H.82 (Tru-Scint AD)S Dessureault, I Koven, R M Reilly, et al.
Pageof 15